v3.24.1.u1
Basic and Diluted Net Income (Loss) Per Share (Tables)
3 Months Ended
Mar. 31, 2024
Basic and Diluted Net Income (Loss) Per Share  
Schedule of EPS amounts for all periods and the basic and diluted weighted-average shares outstanding used in the calculation

For the Three Months Ended 

March 31,

    

2024

    

2023

    

(In thousands, except per share amounts)

Net income (loss)

 

$

(108,375)

 

$

272,845

 

Less: Net income (loss) attributable to noncontrolling interests, net of tax

 

(999)

 

19,311

Net income (loss) attributable to EchoStar - Basic

 

(107,376)

 

253,534

 

Interest on dilutive Convertible Notes, net of tax (1)

Net income (loss) attributable to EchoStar - Diluted

$

(107,376)

$

253,534

Weighted-average common shares outstanding - Class A and B common stock:

Basic

 

271,519

 

269,833

Dilutive impact of Convertible Notes (2)(3)

37,550

Dilutive impact of stock awards outstanding (3)

 

 

27

Diluted

 

271,519

 

307,410

Earnings per share - Class A and B common stock:

Basic net income (loss) per share attributable to EchoStar

 

$

(0.40)

 

$

0.94

 

Diluted net income (loss) per share attributable to EchoStar

 

$

(0.40)

 

$

0.82

 

(1)For the three months ended March 31, 2023, substantially all of our interest expense was capitalized. See Note 2 for further information.
(2)We repurchased or redeemed the principal balance of our 2 3/8% Convertible Notes due 2024 as of March 15, 2024, the instrument’s maturity date.
(3)For the three months ended March 31, 2024, the dilutive impact of 33 million weighted-average shares of Class A common stock were excluded from the computation of Diluted net income (loss) per share attributable to EchoStar because the effect would have been anti-dilutive as a result of the net loss attributable to EchoStar in the period.
Schedule of anti-dilutive securities not included in the diluted EPS calculation

As of March 31,

    

2024

    

2023

 

(In thousands)

Anti-dilutive stock awards

11,417

10,849

Performance/market based options

    

4,556

5,020

Restricted Performance Units/Awards

243

Common stock warrants

16,151

16,151

Total

32,124

32,263